(NASDAQ:BENF), DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 second quarter, which ended September 30, 2025. Commenting on the […]

(Other OTC:RNGE),(OTC US:RNGE), Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for the third quarter ended September 30, 2025. Range Impact's Quarterly Report on Form 10-Q for

COSCIENS Biopharma Inc. Announces Leadership Change GlobeNewswire November 14, 2025 TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, announced today that Peter H. Puccetti, CFA, Chairman of the Company's board of directors (the

Beneficient Reports Results for Second Quarter Fiscal 2026 Second quarter results highlight improved cost management capital structure enhancements GlobeNewswire November 14, 2025 DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of

Range Impact Reports 3Q 2025 Financial Results GlobeNewswire November 14, 2025 Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for the third quarter ended September 30, 2025.

(NASDAQ:PROP),(OTC US:CRKR),(Other OTC:CRKR),(OTC US:CRKRD),(Other OTC:CRKRD), Total Revenue of $77.7 million, an increase of approximately 15% quarter-over-quarter Net Income of $1.3 million Record Adjusted EBITDA of $56.3 million, an increase of over 45% quarter-over-quarter Approximately 10% increase in quarterly production to a total of 23,029 Boe/d per day (52% oil / 72% liquids) Current production rate

Prairie Operating Co. Announces Third Quarter 2025 Results GlobeNewswire November 14, 2025 Total Revenue of $77.7 million, an increase of approximately 15% quarter-over-quarter Net Income of $1.3 million Record Adjusted EBITDA of $56.3 million, an increase of over 45% quarter-over-quarter Approximately 10% increase in quarterly production to a total of 23,029 Boe/d per day (52%

(NASDAQ:POAI), PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today reported financial and operating results for the quarter ended September 30, 2025, and provided a

Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy Company to host investor conference call and webcast on Monday, November 17th, at 9:00am EST GlobeNewswire November 14, 2025 PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers